# FDA drug recall: DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60), 60 Caps; CYMBALTA, Packaged and Distr

> recall · VERIFIED · 2026-06-22

Firm: Direct Rx · Class II · CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

- Company: Direct Rx
- Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.